Signal delivery through the right ventricular septum
US9713723B2 · kind B2 · utility
0Cited by
382References
50Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 2007 |
| Grant date | Jul 25, 2017 |
| Priority date | — |
| Expiry date | Jun 19, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/36564
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A method is provided for use with a human subject. The method includes accessing a cardiac site via a vena cava of the subject, and alleviating heart failure of the subject by applying to the cardiac site, during a refractory period of the site, a refractory-period signal that affects the left ventricle of the subject's heart. Other embodiments are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.